Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : QLT PhotoTherapeutics (QLTI) -- Ignore unavailable to you. Want to Upgrade?

To: Hawkeye who wrote (772)	11/25/1999 12:00:00 PM
From: Hawkeye	Read Replies (1) \| Respond to of 1321

It looks like that press release I just posted came from a press conference this morning in Toronto. Canadians may see this on tonights news and in the paper tomorrow. Media Advisory - Canadian Cancer Society Funded Research Pays Off With Promising Cancer Treatment TORONTO, Nov. 25 /CNW/ - Research funded by the Canadian Cancer Society has led to a treatment that is being heralded as a major therapeutic option for cancer patients. Photodynamic therapy has minimal side effects, can be given on an out-patient basis in a matter of minutes and has been curing some patients with early-stage cancer. Please join us at a news conference where Canadian Cancer Society funded researcher, Dr. Brian Wilson, Ontario Cancer Institute/Princess Margaret Hospital, will present his work and what it means to cancer patients. Date: Thursday, November 25 Time: 11:15 a.m. to 12 p.m. (a light lunch will be provided) Where: Princess Margaret Hospital 610 University Avenue, 7th floor, Room 7-605 Other panel members include: Dr. Norman Marcon, Gastroenterologist at Wellesley Central Site, St. Michael's Hospital (Dr. Marcon is treating patients with photodynamic therapy); Dorothy Lamont, Chief Executive Officer, Canadian Cancer Society/National Cancer Institute of Canada; Peter Vaudry, Canadian Cancer Society Fundraising volunteer; Dr. Ken Shumak, President and Chief Executive Officer, Cancer Care Ontario. Two patients who have been cured through this type of treatment will also be part of the panel. All participants will be available for interviews. -30-